Menopause is not a medical illness, but the healthcare response to it often is inadequate. Many UK women receive vague reassurance or are over-treated with hormone replacement therapy without proper assessment of their individual risk profile.
The menopause transition timeline
Perimenopause—the transition to menopause—typically lasts 4-10 years. Hormone fluctuations cause hot flushes, night sweats, mood changes, sleep disruption, and vaginal dryness. FSH (follicle-stimulating hormone) blood tests can help confirm perimenopause, but diagnosis is mostly clinical based on symptoms and timing.
Natural menopause happens on average at age 51 in the UK, though the range is 45-55. Early menopause (before 45) or premature ovarian insufficiency (before 40) warrant investigation and different management.
Perimenopause symptoms often mimic anxiety or depression. Distinguishing between mood changes from hormone fluctuation and primary mood disorder matters because treatment differs. A GP who takes time to understand your timeline usually gets this right.
Hormone replacement therapy: who actually benefits
HRT is effective for hot flushes and night sweats. It's less clearly effective for mood, joint pain, or brain fog, though many women report improvement. The evidence is strongest for vasomotor symptoms (flushes and sweats).
The breast cancer risk from HRT is real but modest. Combined oestrogen-progestogen therapy increases breast cancer risk by about 1.3 times (meaning roughly 6 extra breast cancers per 1,000 women using it for 5 years, on top of baseline risk). Oestrogen-only therapy (for women without a uterus) carries minimal risk.
NICE guidance recommends HRT is suitable for women with moderate to severe symptoms, particularly if they impact quality of life. If your main complaint is occasional mild flushes, lifestyle measures (cooling strategies, avoiding triggers) might be sufficient before medication.
Duration matters. HRT is typically used 5-8 years. Stopping is usually gradual—abrupt cessation can cause symptom rebound. Your GP should discuss the plan upfront.
Non-HRT options
Selective serotonin reuptake inhibitors (SSRIs) like citalopram or sertraline reduce hot flushes by 40-60% in many women, with fewer side effects than HRT for some. They're particularly useful if you have mood symptoms alongside flushes.
Cognitive behavioural therapy (CBT) specifically designed for menopause symptoms improves quality of life and reduces symptom severity. It's not a cure, but it provides tools to manage the transition better. NHS access is inconsistent; private CBT costs £60-150/session.
Lifestyle approaches matter: regular exercise improves mood and sleep, reduces flush frequency. Weight management helps. Avoiding triggers (spicy food, alcohol, hot environments) provides immediate symptom relief.
Vaginal and sexual health
Vaginal atrophy (dryness and thinning of vaginal tissue) is common after menopause and often overlooked. It causes pain during sex and increases UTI risk. Many women don't mention it to their GP.
Vaginal oestrogen (cream or pessaries) works well and has minimal systemic absorption, so breast cancer risk is not a concern. If HRT is not suitable or desired, vaginal oestrogen often remains an option.
Vaginal moisturisers (hyaluronic acid, polycarbophil) provide temporary relief. Lubricants (silicone or water-based) help with sexual function. Prescription options exist (ospemifene, dehydroepiandrosterone vaginal inserts) for women wanting oral medication.
Bone health screening
Bone density declines after menopause due to falling oestrogen. DEXA scanning (dual-energy X-ray absorptiometry) measures bone density. NICE recommends considering screening if you're over 65 or have risk factors (family history, thin build, steroid use, previous fragility fracture).
Screening at age 50 at menopause for all women is not standard practice and is not routinely funded. If you're concerned about bone health, ask your GP about risk assessment.
Calcium (1,000-1,200 mg daily), vitamin D (800-1,000 IU daily), weight-bearing exercise, and avoiding smoking and excess alcohol all support bone health. Prescription medications (bisphosphonates) are used if bone density is very low.
UK healthcare access for menopause
NHS menopause services are inconsistent across regions. Some areas have specialist menopause clinics; others leave care entirely to GPs. If your GP is dismissive or doesn't discuss options, request a referral to a menopause specialist or gynaecologist.
The Menopause Society has a specialist register if you want private menopause consultation (£150-250). Private consultations often provide more time and discussion of options than rushed NHS appointments.
Ask your GP: Have you calculated my individual breast cancer risk with HRT? Do you routinely prescribe body-identical hormones? Can I be referred to specialist services if I'm not improving? These questions identify GPs who approach menopause thoughtfully.